Alzamend Neuro, Inc.
Clinical trials sponsored by Alzamend Neuro, Inc., explained in plain language.
-
Could a custom vaccine slow Alzheimer's? new trial begins
Disease control OngoingThis study tests a new treatment called ALZN002 for people with mild-to-moderate Alzheimer's disease. It uses a person's own immune cells, trained to target a protein linked to Alzheimer's, to try to slow the disease. The trial involves 30 participants and aims to check if the tr…
Phase: PHASE1, PHASE2 • Sponsor: Alzamend Neuro, Inc. • Aim: Disease control
Last updated May 17, 2026 10:10 UTC
-
New lithium formula tested in healthy brains
Knowledge-focused OngoingThis early-stage study tests a new crystal form of lithium (AL001) against standard lithium carbonate in 6 healthy adults. The goal is to see how much lithium gets into the brain and body, and whether it is safe. Participants take both drugs for 14 days each and undergo MRIs and …
Phase: PHASE1 • Sponsor: Alzamend Neuro, Inc. • Aim: Knowledge-focused
Last updated May 13, 2026 15:59 UTC